Drugs / H5N1 VLP Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00519389 | Jul 2007 → Nov 2008 | influenza | Novavax | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H5N1 VLP Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00519389 ↗ |
| Modality | Vaccine | “H5N1 Virus-Like Particle (VLP) Influenza Vaccine (Recombinant)” NCT00519389 ↗ |